These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10992128)

  • 21. Research in motion: the enigma of Parkinson's disease pathology spread.
    Brundin P; Li JY; Holton JL; Lindvall O; Revesz T
    Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Lewy bodies and glial cytoplasmic inclusions in the brain of Parkinson's disease.
    Mochizuki A; Komatsuzaki Y; Shoji S
    Acta Neuropathol; 2002 Nov; 104(5):534-7. PubMed ID: 12410401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathobiology of the Lewy body.
    Galvin JE; Lee VM; Schmidt ML; Tu PH; Iwatsubo T; Trojanowski JQ
    Adv Neurol; 1999; 80():313-24. PubMed ID: 10410736
    [No Abstract]   [Full Text] [Related]  

  • 25. Lewy bodies in Betz cells of the motor cortex in a patient with Parkinson's disease.
    Wakabayashi K; Mori F; Oyama Y; Kurihara A; Kamada M; Yoshimoto M; Takahashi H
    Acta Neuropathol; 2003 Feb; 105(2):189-92. PubMed ID: 12536231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-occurrence of Parkinson's disease with progressive supranuclear palsy.
    Judkins AR; Forman MS; Uryu K; Hinkle DA; Asbury AK; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2002 May; 103(5):526-30. PubMed ID: 11935271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation.
    Meredith GE; Halliday GM; Totterdell S
    Parkinsonism Relat Disord; 2004 Jun; 10(4):191-202. PubMed ID: 15120093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neuropathology of manganese-induced Parkinsonism.
    Perl DP; Olanow CW
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):675-82. PubMed ID: 17882011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From James Parkinson to Friederich Lewy: leaving landmarks for further research journeys.
    Funct Neurol; 2003; 18(2):63-4. PubMed ID: 12911134
    [No Abstract]   [Full Text] [Related]  

  • 31. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
    Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
    Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of CKII beta subunits in Lewy bodies of Parkinson's disease.
    Ryu MY; Kim DW; Arima K; Mouradian MM; Kim SU; Lee G
    J Neurol Sci; 2008 Mar; 266(1-2):9-12. PubMed ID: 17884098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease.
    Farlow MR; Cummings J
    Dement Geriatr Cogn Disord; 2008; 25(4):301-8. PubMed ID: 18311077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing fetal nerve cell grafts in Parkinson's disease.
    Braak H; Del Tredici K
    Nat Med; 2008 May; 14(5):483-5. PubMed ID: 18463652
    [No Abstract]   [Full Text] [Related]  

  • 35. Histone deacetylase (HDAC) 4 involvement in both Lewy and Marinesco bodies.
    Takahashi-Fujigasaki J; Fujigasaki H
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):562-6. PubMed ID: 16972890
    [No Abstract]   [Full Text] [Related]  

  • 36. [An autopsy case of senile dementia with pathological features of Parkinson's disease].
    Oshima K; Tsuchiya K; Iritani S; Niizato K; Akiyama H; Ikeda K; Arai H
    No To Shinkei; 2004 Jul; 56(7):603-6. PubMed ID: 15379289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Milk consumption and the risk of nigral degeneration.
    Chen H; Marder K
    Neurology; 2016 Feb; 86(6):496-7. PubMed ID: 26658908
    [No Abstract]   [Full Text] [Related]  

  • 39. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
    Tsuboi Y; Dickson DW
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
    Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG
    Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.